v2.3.0.11
Business Combinations (Narrative) (Details) (USD $)
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Jun. 25, 2011
Jun. 25, 2011
Dec. 25, 2010
Sentinelle Medical [Member]
Minimum [Member]
Jun. 25, 2011
TCT International Co [Member]
Maximum [Member]
Dec. 25, 2010
Sentinelle Medical [Member]
Maximum [Member]
Jul. 19, 2011
Maximum [Member]
Beijing Healthcome Technology [Member]
Jun. 25, 2011
Interlace Medical, Inc [Member]
Developed Technology [Member]
Jun. 25, 2011
Sentinelle Medical [Member]
Developed Technology [Member]
Jun. 25, 2011
TCT International Co [Member]
Customer Relationships [Member]
Jun. 25, 2011
Sentinelle Medical [Member]
Non-compete Agreements [Member]
Jun. 25, 2011
TCT International Co [Member]
Business Licenses [Member]
Jun. 25, 2011
TCT International Co [Member]
Trade Names [Member]
Jun. 25, 2011
Interlace Medical, Inc [Member]
Trade Names [Member]
Jun. 25, 2011
Sentinelle Medical [Member]
Trade Names [Member]
Dec. 25, 2010
Sentinelle Medical [Member]
In-process Research and Development [Member]
Jun. 01, 2011
TCT International Co [Member]
Purchase Price Allocation Adjustments [Member]
Jun. 25, 2011
TCT International Co [Member]
Jun. 01, 2011
TCT International Co [Member]
Jun. 25, 2011
Interlace Medical, Inc [Member]
Jun. 25, 2011
Interlace Medical, Inc [Member]
Jan. 06, 2011
Interlace Medical, Inc [Member]
Jul. 19, 2011
Beijing Healthcome Technology [Member]
Jun. 25, 2011
Sentinelle Medical [Member]
Dec. 25, 2010
Sentinelle Medical [Member]
Jun. 25, 2011
Sentinelle Medical [Member]
Sep. 25, 2010
Sentinelle Medical [Member]
Aug. 05, 2010
Sentinelle Medical [Member]
Acquisition of equity interest, percentage                                   100.00%     100.00%           100.00%
Total purchase price                                 $ 141,936,000 $ 141,900,000 $ 213,398,000 $ 213,398,000     $ 114,251,000   $ 114,251,000    
Cash portion of purchase price                                   135,000,000                  
Cash                                   100,000,000 126,798,000 126,798,000 126,800,000 9,800,000 84,751,000   84,751,000   84,800,000
Estimated working capital adjustment                                   6,900,000                  
Deferred purchase price                               35,000,000                      
Maximum additional contingent payment           7,100,000                             225,000,000           250,000,000
Cash flow projections discount rate related to contingent consideration     15.00%   16.00%       10.00%           17.00%       12.70% 12.70% 15.60%           16.50%
Contingent consideration arrangements recorded as compensation expense                                 2,100,000   1,000,000 2,100,000              
Contingent consideration obligation, fair value                                     92,600,000 92,600,000 86,600,000   15,600,000   15,600,000   29,500,000
Contingent consideration fair value adjustments (629,000) 3,546,000                                 3,300,000 6,000,000     2,700,000   9,600,000    
Maximum contingent earn-out payment       200,000,000                                              
Payment of contingent consideration                                             4,300,000        
Compensation expense ratably over the required service period 2,114,000 2,114,000                                                  
General and administrative                                 $ 1,300,000   $ 400,000 $ 400,000           $ 1,200,000  
Reevaluated discount rate in connection with determination of fair value of the contingent consideration liability                                               17.00%      
Finite-lived intangible assets, estimated useful life in years, minimum   2                         10                        
Finite-lived intangible assets, estimated useful life in years, maximum   30                         20                        
Finite-lived intangible assets, estimated useful life, years             15     3     13                            
Finite-lived intangible assets, weighted average useful life, years               19 13.6   10 13   9